By Laura Dyrda
Johnson & Johnson’s orthopedics business reported $2.3 billion in sales for the second quarter.
Here are five key notes:
1. Total sales for the orthopedics line were down 5.6 percent over the same period last year.
2. United States sales were up 2.1 percent, hitting $1.3 billion last quarter.
